0000899243-20-019547.txt : 20200717
0000899243-20-019547.hdr.sgml : 20200717
20200717175211
ACCESSION NUMBER: 0000899243-20-019547
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200715
FILED AS OF DATE: 20200717
DATE AS OF CHANGE: 20200717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wegman Mark N
CENTRAL INDEX KEY: 0001405235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19879
FILM NUMBER: 201034559
MAIL ADDRESS:
STREET 1: 43 OVERLOOK ROAD
CITY: OSSINING
STATE: NY
ZIP: 10562
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-15
0
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001405235
Wegman Mark N
C/O BIOSPECIFICS TECHNOLOGIES CORP.
2 RIGHTER PKWY, DELAWARE CORP. CENTER II
WILMINGTON
DE
19803
1
0
0
0
Common Stock, $0.001 par value
2020-07-15
4
A
0
1726
0.00
A
68888
D
Grant of restricted stock units under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan. The restricted stock units generally will vest in full on the first anniversary of the date of grant.
/s/ Mark N. Wegman, by Carl A. Valenstein, attorney-in-fact
2020-07-17